SCHEMBL7425744

SCHEMBL7425744

COC(=O)Cc1ccc(N(C(N)=O)c2ccccc2)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.50
ALDH1A1 P00352 3/20 0.50
GFER P55789 1/20 0.50
SLC7A5 Q01650 1/20 0.42
HPGD P15428 3/20 0.41
TSHR P16473 3/20 0.41
MAPT P10636 1/20 0.41
NFKB1 P19838 2/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSP90AB1 P08238 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
PDK2 Q15119 1/20 0.39
CYP4F2 P78329 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6825878 0.78 MEN1 (0.50) GAAALDH1A1GFERHPGDTSHR
SCHEMBL5273127 0.76 GAA (0.52) GAAALDH1A1TSHRNFKB1CYP1A2
SCHEMBL5281926 0.75 MTNR1A (0.49) GAAALDH1A1TSHRMAPTNFKB1
SCHEMBL7549706 0.74 CYP3A4 (0.43) GAAALDH1A1HPGDTSHRMAPT
SCHEMBL9207785 0.73 GAA (0.56) GAAALDH1A1GFERSLC7A5HPGD
SCHEMBL27576158 0.73 KDM4E (0.46) GAAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL6823836 0.73 ESR1 (0.40) ALDH1A1NPC1RAB9ATDP1KMT2A
SCHEMBL5273424 0.72 CYP1A2 (0.43) GAAALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL29446278 0.71 GAA (0.72) GAAALDH1A1GFERHPGDTSHR
SCHEMBL3668882 0.71 GAA (0.72) GAAALDH1A1GFERHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 WO disclosed